Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
10/2007
10/31/2007CN101065016A Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
10/31/2007CN101062929A Branching structure functional material based on minami carbazole and preparation method and application thereof
10/31/2007CN101062928A Process for preparing 2-pyrrolidinyl-1h-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism
10/31/2007CN100345912C Metaloxyphthalocyanine compounds
10/31/2007CN100345853C Pyrazolopyrimidine compound and method for producing the same
10/31/2007CN100345852C Quinolinyl-pyrrolopyrazoles
10/31/2007CN100345847C Novel biarylcarboxamides
10/31/2007CN100345830C Condensed heteroaryl derivatives
10/30/2007US7288676 Arylphenyl-substituted cyclic ketoenols
10/30/2007US7288656 Derivatives of N-heterocyclylmethylbenzamides, preparation method thereof and application of same in therapeutics
10/30/2007US7288655 α v integrin receptor antagonists
10/30/2007US7288651 Such as (R)-4-bromo-N-[1-(2,4-dichlorophenyl)-ethyl]-2-(quinoxaline-5-quinoxaline-sulfonylamino)-benzamide via sulfonylation; cholecystokinin receptor modulators
10/30/2007US7288650 Protein kinase inhibitors; anticarcinogenic agents; benign prostatic hyperplasia
10/30/2007US7288648 High temperature crystallization of 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane
10/30/2007US7288549 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
10/30/2007CA2509650C C-6 modified indazolylpyrrolotriazines
10/30/2007CA2288703C Phthalocyanine and use of phthalocyanine as a marking agent
10/30/2007CA2239227C Nitrogen-containing heterocyclic compounds
10/30/2007CA2179650C Bisindolemaleimides and their use as protein kinase c inhibitors
10/25/2007WO2007120575A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/25/2007WO2007120454A1 Azolopyrimidines as inhibitors of cannabinoid 1 activity
10/25/2007WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
10/25/2007WO2007118844A1 Substituted pyrazolopyrimidines, process for their preparation and their use for controlling harmful fungi and compositions comprising them
10/25/2007WO2007118567A1 Active substance fixing onto polymer surfaces
10/25/2007WO2007077508A3 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
10/25/2007WO2007072153A3 Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
10/25/2007WO2002048116A3 Inhibitors of hepatitis c virus ns3 protease
10/25/2007US20070249828 Novel bis-2-difluoro-pyrrolo[2,1-C][1,4]benzodiazepine dimmers
10/25/2007US20070249701 Cyclic amine CCR5 receptor antagonists
10/25/2007US20070249657 1-Aza-Bicyclo3.3.1Nonanes
10/25/2007US20070249645 Such as N-(3-Benzyloxy-phenyl)-N-(4-thiazol-2-yl-pyrimidin-2-yl)-amine; allergic diseases, cancer, neurodegenerative and proliferative disorders, diabetes; inhibitors of GSK-3, Aurora2, and Syk protein kinases
10/25/2007US20070249641 Adenosine a3 receptor modulators
10/25/2007US20070249636 Selected Fused Heterocyclics and Uses Thereof
10/25/2007US20070249634 Triazolopyrimidine Compounds and Use Thereof for Controlling Harmful Fungi
10/25/2007US20070249633 1,2,4-Triazolo[1,5a] Pyrimidines and Use Thereof for Controlling Plant-Pathogenic Fungi
10/25/2007US20070249617 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders
10/25/2007US20070249616 Substituted 1-Benzyl-4-Substituted Piperazine Analogues
10/25/2007US20070249615 Pyridine [3,4-b] Pyrazinones
10/25/2007US20070249612 Substituted 2H-[1,2,4]Triazolo[4,3-A]Pyrazines as Gsk-3 Inhibitors
10/25/2007US20070249611 Dipeptidyl peptidase inhibitors
10/25/2007US20070249610 PROCESS FOR THE PREPARATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTER
10/25/2007US20070249609 Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/25/2007US20070249601 Compounds and therapeutical use thereof
10/25/2007US20070249600 Chemical compounds
10/25/2007US20070249591 Biaryl Amino Acids and Their Use in Dna Binding Oligomers
10/25/2007US20070249590 Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disorders
10/25/2007US20070249588 Nicotinic Acetylcholine Receptor Ligands
10/25/2007US20070249484 Process for the Photoactivation and use of a Catalyst by an Inverted Two-Stage Procedure
10/25/2007US20070248672 Indole and Azaindole Derivatives with Antitumor Action
10/25/2007DE102006017492A1 Wirkstoff-Fixierung auf Polymer-Oberflächen Drug fixation on polymer surfaces
10/25/2007CA2631871A1 Tetracyclic kinase inhibitors
10/24/2007EP1847541A1 Fused pyrimidine derivative and uses thereof
10/24/2007EP1847267A2 Method of photodynamic diagnosis for vascular diseases
10/24/2007EP1846410A2 Dihydroquinazolinones as 5ht modulators
10/24/2007EP1846409A1 Octahydropyrrolo[3,4-c]pyrrole derivatives
10/24/2007EP1846408A1 5-membered annelated heterocyclic pyrimidines as kinase inhibitors
10/24/2007EP1846406A1 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
10/24/2007EP1846401A1 New 4-aminoquinoline derivatives as antimalarials
10/24/2007EP1846392A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors
10/24/2007EP1845993A2 Novel adenosine a3 receptor modulators
10/24/2007EP1581535B1 Pyrrolopyridazine derivatives
10/24/2007EP1534710B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors
10/24/2007CN101061112A (Spirocyclylamido) aminothiophene compounds as c-Kit proto-oncogene inhibitors
10/24/2007CN101060838A Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
10/24/2007CN101058582A Method of preparing esopiclone intermediate 6-(5-chloro-2-pyridyl)-5-hydro-7-oxy-6,7-dihydro-5H-pyrrolo[3,4-b] pyrazine
10/24/2007CN101058581A Method of preparing eszopiclone intermediate 6-(5-chloro-2-pyridyl)-5,7-dioxy-6,7-dihydro-5H-pyrrolo[3,4-b] pyrazine
10/24/2007CN100344631C New compound, its synthetic method and use
10/24/2007CN100344630C Process for preparing 2-pyrrolidinyl-3h,5h-pyrrolo[3,2-d]pyrimidine -4-ketone derivative
10/24/2007CN100344629C Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors
10/24/2007CN100344615C Production of N-(pyrrolo[2,3-d] pyrimidine-5-) acyl glusate derivative and intermediate
10/24/2007CN100344232C Medicine for resisting plant powdery mildew, its preparation method and application
10/23/2007US7285622 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides
10/23/2007US7285619 E.g, 1-([-4-oxo-N2-(12-methyl-1-oxotetradecyl)-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B and 1-[N2-[[4'-octyloxy)-[1,1'-biphenyl]-4-yl]-carbonyl]-4-oxo-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B
10/23/2007US7285569 Tricycles, their manufacture and use as pharmaceutical agents
10/23/2007US7285561 Imidazo-substituted compounds as p38 kinase inhibitors
10/23/2007US7285559 Imidazo-substituted pyrido[2,3-d]pyrimidinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
10/23/2007US7285558 Helicobacter infections; bactericides
10/23/2007US7285555 Promoting microtube polymerization; drug resistanct cancer
10/23/2007US7285550 Triazolotriazines and pyrazolotriazines and methods of making and using the same
10/23/2007US7285546 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
10/23/2007US7285441 Field effect transistor and method of manufacturing the same
10/23/2007US7285379 Complex of albumin and porphyrin; mixing under inert gas albumin and porphyrin
10/23/2007US7285137 4,5-diamino-1,2-dimethyl-1,2-dihydropyrazol-3-one; oxidation dyes for human hair
10/18/2007WO2007117494A1 Deazapurines useful as inhibitors of janus kinases
10/18/2007WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof
10/18/2007WO2007117053A1 New diaza-bridged heterocycle derivatives and solid-phase preparation method thereof
10/18/2007WO2007116011A2 Substituted triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and substances containing the same
10/18/2007WO2007115999A1 2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
10/18/2007WO2007115947A1 Pyrrolo-quinoxalinone derivatives as antibacterials
10/18/2007WO2007115620A2 Novel cyclobutyl compounds as kinase inhibitors
10/18/2007WO2007115473A1 Pyrrole derivatives inhibitors, their curative uses
10/18/2007WO2007100990A3 Octahydro-pyrrolo[3,4-b] pyrrole derivatives and their use as histamine-3 receptor ligands
10/18/2007WO2007097470A3 Fused nitrogen- comprising heterocyclic compound
10/18/2007WO2007076473A3 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases
10/18/2007WO2006091647A3 Method of preferentially inducing the biosynthesis of interferon
10/18/2007US20070244322 Process for Preparing Tetrahydrobiopterin and Analogs of Tetrahydrobiopterin
10/18/2007US20070244145 Cyclic Amine Compound
10/18/2007US20070244132 Fused Heterocyclic Compound
10/18/2007US20070244113 Compounds and therapeutical use thereof
10/18/2007US20070244111 Pyrazolopyrimidines